Landscape Assessment of Antihypertensive Medicines and Blood Pressure Devices in Three Countries
- December 15th, 2019
- Research Summary
- Bracken, H., Bousiéguez, M., Frye, L.J.
This report summarizes the findings from a landscape assessment of antihypertensive medicines and blood pressure devices in Uganda, Mexico and India.
The specific objectives of the assessment were to:
1. Assess national standards and guidelines for (a) the diagnosis, monitoring and treatment of severe hypertension in pregnancy and (b) the procurement and supply of blood pressure monitoring devices and the most commonly used antihypertensive medicines for treatment of severe hypertension in pregnancy.
2. Measure the availability, source, cost and procurement process of blood pressure devices and medicines for treatment of severe hypertension in pregnancy (nifedipine, labetalol, methyldopa and hydralazine) at public sector health care facilities and private sector medicine outlets.
Support for this project was funded by PATH in its capacity as the Secretariat of the Reproductive Health Supplies Coalition.